Pricing Log in Create free account

Abivax SA Sponsored ADR (ABVX) vs Praxis Precision Medicines, Inc. (PRAX)

Abivax SA Sponsored ADR and Praxis Precision Medicines, Inc. are both Biotechnology companies. Abivax SA Sponsored ADR is the larger, with a market value of $8.1B against $6.9B — 1.2× the size. Across the 11 metrics below, Praxis Precision Medicines, Inc. leads on 9 and Abivax SA Sponsored ADR on 2.

Valuation

Metric ABVX PRAX Biotechnology median
P/E n/m n/m 8.50
P/S n/m 823.42 9.71
P/B 16.42 5.25 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 734.73 9.21
Earnings yield (6.90%) (5.35%) (33.15%)
Free cash flow yield (3.23%) (4.35%) (25.50%)

Profitability

Metric ABVX PRAX Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (249.78%) (38.86%) (56.36%)
Return on assets (137.67%) (36.80%) (48.04%)
Return on invested capital 0.00% (40.58%) 0.00%

Growth

Metric ABVX PRAX Biotechnology median
Revenue growth (TTM) — 249.53% 6.02%
EPS growth (last fiscal year) (80.20%) (32.03%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ABVX PRAX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.97 15.73 4.72
Net debt to EBITDA 2.19 1.82 0.96

Dividend

Metric ABVX PRAX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ABVX PRAX Biotechnology median
Market cap 8.09b 6.93b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack